ACTRN12620000675921已完成1 期
A Phase 1 Clinical Trial in Healthy Participants to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PRAX-944 Administered in a Within-Participant Escalating Dose Paradigm
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 55 Years（—）
- 性别
- All
入选标准
- •Female or male and between the ages of 18 and 55 years, inclusive.
- •- Weight of at least 50 kg with body mass index (BMI) between 18 and 32 kg/m2 (inclusive).
排除标准
- •- Ongoing or history of any psychiatric, medical or surgical condition that might jeopardize the participant’s safety or interfere with the absorption, distribution, metabolism or excretion of the study drug.
- •- Any abnormal ECG, laboratory value or physical examination
- •- Positive breath test for ethanol, urine drug screen, urine cotinine test
- •- Use of systemic prescription medications or over-the-counter (OTC) medication, including multivitamins, and dietary and herbal supplement within 2 weeks
- •- Use of any experimental or investigational drug or device within 30 days
- •- Donation or loss of greater than or equal to 400 mL blood within 8 weeks and/or donation of plasma within 7 days
研究者
相似试验
已完成
1 期
A Trial in Healthy Participants to Evaluate the Pharmacokinetics, Safety, Tolerability and Food Effects of Multiple Forms of PRAX-114.DepressionACTRN12620000522910Praxis Precision Medicines Australia, Pty Ltd85
已完成
1 期
A randomized, placebo controlled, double blind, phase 1 study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single escalating doses of SAN-300 when administered to healthy subjects and patients with rheumatoid arthritisActive Rheumatoid ArthritisInflammatory and Immune System - Rheumatoid arthritisACTRN12611000123943Santarus, Inc.74
已完成
不适用
A Phase I, open label trial in healthy subjects to evaluate the central nervous receptor occupancy of pipamperone at the 5-HT2A and D2 receptor by means of Positron Emission Tomography.major depressive disorder10027946depressionNL-OMON34843PharmaNeuroBoost NV10
暂停
1 期
Drug interaction assessment of GSK3882347 in healthy participants aged 18 to 65 yearsHealthy volunteer drug interaction studyISRCTN16147016GlaxoSmithKline (United Kingdom)30
已完成
不适用
A phase 1 study in healthy volunteers to determine the dermatopharmacokinetics of topically applied diclofenac in combination with the novel penetration enhancer Tocopheryl Phosphate Mixture (TPM), compared with Votaren(registered trademark) gelMuscular or joint pain relief in healthy volunteers currently experiencing no painOther - Research that is not of generic health relevance and not applicable to specific health categories listed aboveACTRN12609000505202Phosphagenics Limited24